Page last updated: 2024-10-26

valproic acid and Duncan Disease

valproic acid has been researched along with Duncan Disease in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dowdell, KC1
Pesnicak, L1
Hoffmann, V1
Steadman, K1
Remaley, AT1
Cohen, JI1
Straus, SE1
Rao, VK1
Fujii, K1
Suzuki, N1
Yamamoto, T1
Suzuki, D1
Iwatsuki, K1

Other Studies

2 other studies available for valproic acid and Duncan Disease

ArticleYear
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS).
    Experimental hematology, 2009, Volume: 37, Issue:4

    Topics: Animals; Apoptosis; Autoimmune Diseases; Cell Proliferation; Cells, Cultured; Disease Models, Animal

2009
Valproic acid inhibits proliferation of EB virus-infected natural killer cells.
    Hematology (Amsterdam, Netherlands), 2012, Volume: 17, Issue:3

    Topics: Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Dose-Response Relationship

2012